These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7872663)

  • 1. A multiwell assay for inhibitors of phosphatidylinositol-3-kinase and the identification of natural product inhibitors.
    Frew T; Powis G; Berggren M; Abraham RT; Ashendel CL; Zalkow LH; Hudson C; Qazia S; Gruszecka-Kowalik E; Merriman R
    Anticancer Res; 1994; 14(6B):2425-8. PubMed ID: 7872663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative analysis of the photosensitized inhibition of growth-factor regulated protein kinases by hypericin-derivatives.
    Agostinis P; Donella-Deana A; Cuveele J; Vandenbogaerde A; Sarno S; Merlevede W; de Witte P
    Biochem Biophys Res Commun; 1996 Mar; 220(3):613-7. PubMed ID: 8607812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances with phospholipid signalling as a target for anticancer drug development.
    Powis G; Berggren M; Gallegos A; Frew T; Hill S; Kozikowski A; Bonjouklian R; Zalkow L; Abraham R; Ashendel C
    Acta Biochim Pol; 1995; 42(4):395-403. PubMed ID: 8852330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of c-erbB-2 expression an activity in human ovarian carcinoma cells by hypericin.
    Hwang MS; Yum YN; Joo JH; Kim S; Lee KK; Gee SW; Kang HI; Kim OH
    Anticancer Res; 2001; 21(4A):2649-55. PubMed ID: 11724334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multisample assay for inhibitors of phosphatidylinositol phospholipase C: identification of naturally occurring peptide inhibitors with antiproliferative activity.
    Hill SR; Bonjouklian R; Powis G; Abraham RT; Ashendel CL; Zalkow LH
    Anticancer Drug Des; 1994 Aug; 9(4):353-61. PubMed ID: 7916901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emodin negatively affects the phosphoinositide 3-kinase/AKT signalling pathway: a study on its mechanism of action.
    Olsen BB; Bjørling-Poulsen M; Guerra B
    Int J Biochem Cell Biol; 2007; 39(1):227-37. PubMed ID: 17018259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the mechanism of phosphatidylinositol 3-kinase inhibition by wortmannin and related analogs.
    Norman BH; Shih C; Toth JE; Ray JE; Dodge JA; Johnson DW; Rutherford PG; Schultz RM; Worzalla JF; Vlahos CJ
    J Med Chem; 1996 Mar; 39(5):1106-11. PubMed ID: 8676346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro evaluation of new wortmannin esters: potent inhibitors of phosphatidylinositol 3-kinase.
    Creemer LC; Kirst HA; Vlahos CJ; Schultz RM
    J Med Chem; 1996 Dec; 39(25):5021-4. PubMed ID: 8960564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the kinetic properties of the lipid- and protein-kinase activities of the p110alpha and p110beta catalytic subunits of class-Ia phosphoinositide 3-kinases.
    Beeton CA; Chance EM; Foukas LC; Shepherd PR
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):353-9. PubMed ID: 10947948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purine-based inhibitors of inositol-1,4,5-trisphosphate-3-kinase.
    Chang YT; Choi G; Bae YS; Burdett M; Moon HS; Lee JW; Gray NS; Schultz PG; Meijer L; Chung SK; Choi KY; Suh PG; Ryu SH
    Chembiochem; 2002 Sep; 3(9):897-901. PubMed ID: 12210991
    [No Abstract]   [Full Text] [Related]  

  • 11. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase.
    Powis G; Bonjouklian R; Berggren MM; Gallegos A; Abraham R; Ashendel C; Zalkow L; Matter WF; Dodge J; Grindey G
    Cancer Res; 1994 May; 54(9):2419-23. PubMed ID: 8162590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of wortmannin analogs on bone in vitro and in vivo.
    Sato M; Bryant HU; Dodge JA; Davis H; Matter WF; Vlahos CJ
    J Pharmacol Exp Ther; 1996 Apr; 277(1):543-50. PubMed ID: 8613966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of phosphatidylinositol-3'-kinase prevents induction of endotoxin tolerance in vitro.
    Bowling WM; Flye MW; Qiu YY; Callery MP
    J Surg Res; 1996 Jun; 63(1):287-92. PubMed ID: 8661212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).
    Vlahos CJ; Matter WF; Hui KY; Brown RF
    J Biol Chem; 1994 Feb; 269(7):5241-8. PubMed ID: 8106507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylinositol 3-kinase inhibitor, wortmannin, inhibits 5-hydroxytryptamine-mediated potentiation of platelet aggregation induced by epinephrine.
    Shah BH; Saeed SA
    Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):157-64. PubMed ID: 8556270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of echiguanine analogs and their ribofuranosyl glycosides that inhibit phosphatidylinositol 4-kinase.
    Saito Y; Kato K; Umezawa K
    Nucleic Acids Symp Ser; 1997; (37):13-4. PubMed ID: 9585975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues.
    Berggren MI; Gallegos A; Dressler LA; Modest EJ; Powis G
    Cancer Res; 1993 Sep; 53(18):4297-302. PubMed ID: 8395981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both phosphatidylinositol 3-kinase and phosphatidylinositol 4-kinase products are increased by antigen receptor signaling in B cells.
    Gold MR; Aebersold R
    J Immunol; 1994 Jan; 152(1):42-50. PubMed ID: 8254204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of 5-hydroxytryptamine(2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle.
    Banes A; Florian JA; Watts SW
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1179-87. PubMed ID: 10565840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth factor-dependent survival of rodent fibroblasts requires phosphatidylinositol 3-kinase but is independent of pp70S6K activity.
    Yao R; Cooper GM
    Oncogene; 1996 Jul; 13(2):343-51. PubMed ID: 8710373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.